» Articles » PMID: 39619056

Exosomes from Adipose-Derived Mesenchymal Stromal Cells Prevent Medication-Related Osteonecrosis of the Jaw by Inhibiting Macrophage M1 Polarization and Pyroptosis

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2024 Dec 2
PMID 39619056
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Exosomes from mesenchymal stromal cells (MSCs) can prevent the development of medication-related osteonecrosis of the jaw (MRONJ) by promoting tooth socket wound healing; however, the exact mechanism remains to be clarified. In this study, our aim was to explore the mechanisms of exosomes derived from adipose-derived mesenchymal stromal cells (ADSCs) in preventing MRONJ by focusing on macrophage M1 polarization and pyroptosis.

Methods: The MRONJ model was established by the administration of zoledronate and tooth extraction. Exosomes isolated from the supernatant of ADSCs were mixed with hydrogel and locally injected into the extraction site after tooth extraction. Stereoscope observations, micro computed tomography (microCT), and histological analysis were used to assess tooth socket wound healing.

Results: The results showed that exosomes could effectively avoid MRONJ via accelerating gingival wound healing and tooth socket bone regeneration. Mechanistically, zoledronate triggered the NF-κB signaling pathway and promoted p65 transferring into the nucleus in macrophages, resulting in macrophage M1 polarization and pyroptosis-mediated tissue inflammation, while exosomes could reduce macrophage pyroptosis and pro-inflammation cytokines release by suppressing the NF-κB/NLRP3/IL-1β axis. Additionally, IL-1RA derived from exosomes plays a key role in preventing MRONJ. Pyroptosis-related and inflammatory-related processes were upregulated in MRONJ patients further confirmed by assessing MRONJ gingival samples and healthy gingival tissues.

Conclusion: ADSCs-derived exosomes could effectively promote tooth socket healing and prevent MRONJ by inhibiting M1 macrophage activation and pyroptosis by blocking the NF-κB/NLRP3/IL-1β axis.

References
1.
Kaibuchi N, Iwata T, Yamato M, Okano T, Ando T . Multipotent mesenchymal stromal cell sheet therapy for bisphosphonate-related osteonecrosis of the jaw in a rat model. Acta Biomater. 2016; 42:400-410. DOI: 10.1016/j.actbio.2016.06.022. View

2.
Isaac R, Reis F, Ying W, Olefsky J . Exosomes as mediators of intercellular crosstalk in metabolism. Cell Metab. 2021; 33(9):1744-1762. PMC: 8428804. DOI: 10.1016/j.cmet.2021.08.006. View

3.
Rao Z, Zhu Y, Yang P, Chen Z, Xia Y, Qiao C . Pyroptosis in inflammatory diseases and cancer. Theranostics. 2022; 12(9):4310-4329. PMC: 9169370. DOI: 10.7150/thno.71086. View

4.
Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X . Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther. 2021; 6(1):128. PMC: 8005494. DOI: 10.1038/s41392-021-00507-5. View

5.
Ruggiero S, Dodson T, Aghaloo T, Carlson E, Ward B, Kademani D . American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update. J Oral Maxillofac Surg. 2022; 80(5):920-943. DOI: 10.1016/j.joms.2022.02.008. View